Susceptibility of various oral antibacterial agents against extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae

Journal of Infection and Chemotherapy

Volumn 20, Issue 1, 2014, Pages 48-51

  Nakamura, Tatsuya ^a   Komatsu, Masaru ^b   Yamasaki, Katsutoshi ^c   Katsutoshi, Saori ^d   Higuchi, Takeshi ^e   Ono, Tamotsu ^f   Nishio, Hisaaki ^g   Sueyoshi, Noriyuki ^h   Kida, Kaneyuki ⁱ   Satoh, Kaori ^j   Toda, Hirofumi ^j   Toyokawa, Masahiro ^k   Nishi, Isao ^k   Sakamoto, Masako ^l   Akagi, Masahiro ^m   Mizutani, Tetsu ^m   Nakai, Isako ⁿ   Kofuku, Tomomi ⁿ   Orita, Tamaki ^o   Zikimoto, Takuya ^a   Natsume, Seiko ^p   Wada, Yasunao ^q   more..

^a KOBE UNIVERSITY HOSPITAL   (Japan)

^b TENRI HEALTH CARE UNIVERSITY   (Japan)

^c WAKAYAMA ROSAI HOSPITAL   (Japan)

^d TENRI HOSPITAL   (Japan)

^e KYOTO UNIVERSITY HOSPITAL   (Japan)

^f KYOTO SECOND RED CROSS HOSPITAL   (Japan)

^g Shiga Medical Center for Adults   (Japan)

^h Shiga Hospital of Social Insurance   (Japan)

ⁱ OTSU RED CROSS HOSPITAL   (Japan)

^j KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k OSAKA UNIVERSITY HOSPITAL   (Japan)

^l The Research Foundation for Microbial Diseases of Osaka University   (Japan)

^m OSAKA POLICE HOSPITAL   (Japan)

ⁿ SUMITOMO HOSPITAL   (Japan)

^o Takarazuka Municipal Hospital   (Japan)

^p KANSAI MEDICAL UNIVERSITY MEDICAL CENTER   (Japan)

^q HYOGO COLLEGE OF MEDICINE HOSPITAL   (Japan)

more..

Author keywords

CTX M; Enterobacteriaceae; ESBL; Oral drug

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; CEFEPIME; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CEFTIBUTEN; CHLORAMPHENICOL; COLISTIN; COTRIMOXAZOLE; FOSFOMYCIN; FROPENEM; LEVOFLOXACIN; MINOCYCLINE; SITAFLOXACIN; SULTAMICILLIN; BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; COMPARATIVE STUDY; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; DRUG EFFECTS; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; METABOLISM; MICROBIAL SENSITIVITY TEST; PROCEDURES;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS;

EID: 84903712453     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1016/j.jiac.2013.08.004     Document Type: Article

References (16)

1. CDC. Community-acquired methicillin-resistant Staphylococcus aureus infectionseMichigan. MMWR 1981;30:185-7.
2. CDC. Multidrug-resistant TB (MDR-TB): 2012 Update.
3. Doi Y, Adams J, O'Keefe A, Quereshi Z, Ewan L, Paterson DL. Community-acquired extended-spectrumb-lactamase producers, United States. Emerg Infect Dis 2007;13:1121-3. (Pubitemid 47048102)
4. Woodford N, Ward ME, Kaufmann ME, Turton J, Fagan EJ, James D, et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrumb-lactamases in the UK. J Antimicrob Chemother 2004;54:735-43.
5. Ho PL, Poon WW, Loke SL, Leung MS, Chow KH, Wong RC, et al. Community emergence of CTX-M type extended-spectrumb-lactamases among urinary Escherichia coli from women. J Antimicrob Chemother 2007;60:140-4. (Pubitemid 47073288)
6. Freeman JT, McBride SJ, Heffernan H, Bathgate T, Pope C, Ellis-Pegler RB. Community-onset genitourinary tract infection due to CTX-M-15eproducing Escherichia coli among travelers to the Indian subcontinent in New Zealand. Clin Infect Dis 2008;47:689-92.
7. Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983;11:315-7. (Pubitemid 14213754)
8. Arlet G, Philippon A. Construction by polymerase chain reaction and use of intragenic DNA probes for three main types of transferableb-lactamases (TEM, SHV, CARB). FEMS Microbiol Lett 1991;66:19-25.
9. Pitout JD, Laupland KB. Extended-spectrumb-lactamaseeproducing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008;8: 159-66. (Pubitemid 351249250)
10. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: fifteenth informational supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2010. Document M100-S20.
11. Hiramatsu K, Kadot J. Breakpoints and pharmacokinetic-pharmacodynamic theory for respiratory infections and sepsis. Jpn J Chemother 2012;60:12-7.
12. Frank C, Werber D, Cramer JP, Askar M, Faber M, an der Heiden M, et al. Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany. N Engl J Med 2011;365:1771-80.
13. Warren RE, Ensor VM, O'Neill P, Butler V, Taylor J, Nye K, et al. Imported chicken meat as a potential source of quinolone-resistant Escherichia coli producing extended-spectrumb-lactamases in the UK. J Antimicrob Chemother 2008;61:504-8. (Pubitemid 351321121)
14. Ishihara T, Furukawa I, Kuroki Y, Kamiyama T. Isolation of extended-spectrum b-lactamase-producing bacteria from retail chicken meat and diarrhea patients at community hospitals. Jpn J Food Microbiol 2011;28:123e7.
15. Gilbert DN, Moellering RC, Eliopoulos GM, Chambers HF, Saag MS. The SANFORD GUIDE to antimicrobial therapy. 41th ed.; 2011.
16. Kanda H, Kurosaka Y, Fujikawa K, Chiba M, Yamachika S, Okumura R, et al. In vitro and in vivo antibacterial activity of sitafloxacin. Jpn J Chemother 2008;56:1-7. (Pubitemid 351662837)